Avolio, Alfonso Wolfango
 Distribuzione geografica
Continente #
NA - Nord America 7.470
EU - Europa 5.512
AS - Asia 5.299
SA - Sud America 1.080
Continente sconosciuto - Info sul continente non disponibili 199
AF - Africa 127
OC - Oceania 12
Totale 19.699
Nazione #
US - Stati Uniti d'America 7.225
SG - Singapore 2.262
DE - Germania 1.574
CN - Cina 1.445
SE - Svezia 903
BR - Brasile 857
IT - Italia 727
UA - Ucraina 538
FR - Francia 476
VN - Vietnam 468
GB - Regno Unito 309
IE - Irlanda 274
FI - Finlandia 190
PL - Polonia 180
BD - Bangladesh 168
ID - Indonesia 167
IN - India 144
JP - Giappone 140
CA - Canada 128
TR - Turchia 97
HK - Hong Kong 90
RU - Federazione Russa 89
AR - Argentina 76
MX - Messico 59
IQ - Iraq 58
BE - Belgio 43
KR - Corea 42
ZA - Sudafrica 41
EC - Ecuador 39
ES - Italia 35
VE - Venezuela 32
IR - Iran 29
CO - Colombia 28
NL - Olanda 27
AT - Austria 26
PK - Pakistan 26
SA - Arabia Saudita 24
LT - Lituania 22
CH - Svizzera 20
UZ - Uzbekistan 20
KE - Kenya 18
CL - Cile 17
MA - Marocco 17
RO - Romania 15
AE - Emirati Arabi Uniti 14
MY - Malesia 13
PH - Filippine 13
TH - Thailandia 13
TN - Tunisia 12
JM - Giamaica 11
CZ - Repubblica Ceca 10
EG - Egitto 10
EU - Europa 10
PY - Paraguay 10
UY - Uruguay 9
AU - Australia 8
CI - Costa d'Avorio 8
HN - Honduras 8
KZ - Kazakistan 8
PE - Perù 8
AZ - Azerbaigian 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
JO - Giordania 7
NP - Nepal 7
BG - Bulgaria 6
DK - Danimarca 6
GR - Grecia 5
MD - Moldavia 5
PA - Panama 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
EE - Estonia 4
GT - Guatemala 4
OM - Oman 4
PT - Portogallo 4
TW - Taiwan 4
AO - Angola 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
GD - Grenada 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AL - Albania 2
BN - Brunei Darussalam 2
BW - Botswana 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 19.478
Città #
Singapore 1.091
Ashburn 882
Chandler 772
San Jose 659
Jacksonville 291
Beijing 286
Dublin 264
San Mateo 235
Los Angeles 200
New York 187
Ann Arbor 177
Munich 165
Rome 163
Nanjing 155
Ho Chi Minh City 154
Jakarta 142
Lauterbourg 140
Wilmington 131
Hanoi 126
Tokyo 124
Boston 120
The Dalles 119
Milan 117
Warsaw 114
Hefei 102
Marseille 98
Santa Clara 93
Woodbridge 90
Seattle 87
Frankfurt am Main 84
Mcallen 83
Buffalo 82
Houston 82
Lawrence 82
Dallas 81
Chicago 79
Dearborn 77
Hong Kong 75
Nürnberg 72
Bremen 68
Redwood City 68
Fairfield 64
Nanchang 62
Izmir 60
Helsinki 58
São Paulo 56
Moscow 54
Shenyang 54
Cattolica 49
Hangzhou 47
Princeton 47
Hebei 42
University Park 41
Zhengzhou 41
Brussels 39
Tianjin 37
Lancaster 36
Council Bluffs 35
Andover 33
St Louis 33
Atlanta 31
London 31
Toronto 31
Kraków 30
Augusta 29
Phoenix 29
Shanghai 29
Johannesburg 28
Mountain View 28
Changsha 27
Guangzhou 27
Kunming 27
Nuremberg 27
Turku 26
Baghdad 25
Rio de Janeiro 25
Seoul 25
Boardman 24
Montréal 24
Dhaka 23
Pune 23
Belo Horizonte 22
Brooklyn 22
Da Nang 22
Kent 22
Norwalk 22
San Francisco 21
Charlotte 20
Chengdu 20
Denver 20
Montreal 20
Curitiba 19
Detroit 19
Jiaxing 19
Paris 19
Haiphong 18
Ningbo 18
Tukwila 18
Fremont 17
Guayaquil 17
Totale 10.049
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 416
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 383
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 356
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 335
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 245
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 234
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 214
Duplex Doppler in the postoperative monitoring of liver transplant recipients 208
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 208
Accidental transplantation of a kidney with stones: case report 201
Liver transplantation in patients with alcoholic liver disease: A retrospective study 193
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 191
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 189
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 189
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 187
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 185
Intensive Care Unit-Acquired Weakness after Liver Transplantation: Analysis of Seven Cases and a Literature Review 182
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 173
Discrepancy Between Conventional Coagulation Tests and Thromboelastography During the Early Postoperative Phase of Liver Resection in Neoplastic Patients: A Prospective Study Using the New-Generation TEG®6s 172
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 170
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 168
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 168
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 165
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 165
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 163
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 163
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 162
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 161
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 161
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 161
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 160
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 160
Prediction of 6-month survival after liver transplantation using Cox regression. 158
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 158
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 155
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 155
Development and validation of a comprehensive model to predict complications after hepatectomy 155
Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis 153
Is primary nonfunction still a suitable indication for liver retransplantation? 153
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 153
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 152
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 151
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 151
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 150
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 149
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 149
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 149
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 148
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 147
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 147
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 146
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 145
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 145
Psychological risk factors for graft rejection among liver transplant recipients 142
Model for end-stage liver disease dynamic stratification of survival benefit 141
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 139
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 138
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 138
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 137
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 134
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 134
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 133
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 133
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 133
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 133
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 132
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 131
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 131
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 131
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 130
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 129
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 129
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 129
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 129
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 128
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 128
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 127
Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 126
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 126
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 123
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 122
Primary difunction after liver trasplantation: donor or recipients fault? 121
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 118
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 118
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 117
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 117
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 116
Celiac axis compression syndrome in liver transplantation 115
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 113
Clinical problems of the transplanted kidney 113
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 113
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 113
Should retransplantation still be considered for primary non-function after liver transplantation? 112
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 111
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 111
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 109
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 109
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 108
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 108
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 106
Totale 15.591
Categoria #
all - tutte 79.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.104 0 0 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/20252.573 45 61 199 95 202 113 66 97 414 282 568 431
2025/20266.537 1.008 204 404 768 1.025 303 1.046 289 368 511 244 367
2026/2027923 392 266 265 0 0 0 0 0 0 0 0 0
Totale 19.699